BASEL, Switzerland, March 3, 2014 /PRNewswire/ --
- ELATUS™ fungicide receives regulatory approval in Brazil
- Delivers outstanding control of soybean rust disease
- Higher and more predictable yields for Latin American growers
Syngenta today announced that ELATUS, a breakthrough foliar fungicide, has been approved by the Brazilian authorities. ELATUS is a combination of Syngenta's new SDHI chemistry SOLATENOL™ and AMISTAR®. It offers unrivaled performance against soybean rust, a devastating disease which can significantly impact yields.
ELATUS is already sold in Paraguay and Bolivia and will be available in Brazil for the next season starting in September. It is a major innovation in soybean rust control, offering around 7-10 days more control than current standards even in high disease pressure environments. By using ELATUS as the mainstay of disease control programs, growers benefit from more consistent performance, leading to higher and more predictable yields.
Syngenta Chief Operating Officer, John Atkin, said: "ELATUS is a powerful addition to our leading soybean portfolio and will be an important part of our integrated offers. Latin American soybean growers now have a new tool to control rust and manage resistance. This will enable them to increase production in response to growing global demand while optimizing their use of natural resources."
SOLATENOL has also demonstrated outstanding performance against key diseases in a number of other crops, including wheat, corn and specialty crops. Regulatory submissions have been made in the USA, Canada, Mexico and the EU.
Syngenta is one of the world's leading companies with more than 28,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to www.syngenta.com
Cautionary Statement Regarding Forward-Looking Statements
This document contains forward-looking statements, which can be identified by terminology such as 'expect', 'would', 'will', 'potential', 'plans', 'prospects', 'estimated', 'aiming', 'on track' and similar expressions.Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements.We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties.Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors.This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefor.
Syngenta International AG
Tel: +41 61 323 2323
Fax: +41 61 323 2424
Switzerland +41 61 323 2323
USA + 1 202 737 8913
Switzerland +41 61 323 5059
USA +1 202 737 6521
Switzerland +41 61 323 6793
USA +1 202 737 6520
SOURCE Syngenta International AG